Difference between revisions of "CANON MEDICAL SYSTEMS CORPORATION patent applications published on November 30th, 2023"

From WikiPatents
Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 29: Line 29:
 
Tzu-Cheng LEE
 
Tzu-Cheng LEE
  
 
'''Brief explanation'''
 
- The patent application describes an information processing method for processing x-ray images.
 
- The method involves obtaining three-dimensional image data with a lower radiation dose during a scan of a patient.
 
- A trained neural network is used to detect the presence of artifacts, such as metal artifacts, in the image data.
 
- An information processing apparatus with processing circuitry is used to perform the detection method.
 
- Computer instructions stored in a non-transitory computer readable storage medium enable a computer processor to perform the detection method.
 
 
'''Abstract'''
 
An information processing method processes an x-ray image including the steps of: obtaining first lower-radiation dose three-dimensional image data during a first scan of a patient; and detecting, using a trained neural network, a presence of an artifact (e.g., a metal artifact) in the first lower-radiation dose three-dimensional image data. An information processing apparatus includes processing circuitry for performing the detection method, and computer instructions stored in a non-transitory computer readable storage medium cause a computer processor to performing the detection method.
 
  
 
===MOBILE DIAGNOSIS SYSTEM AND TRANSPORT MANAGEMENT DEVICE ([[US Patent Application 18324256. MOBILE DIAGNOSIS SYSTEM AND TRANSPORT MANAGEMENT DEVICE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18324256]])===
 
===MOBILE DIAGNOSIS SYSTEM AND TRANSPORT MANAGEMENT DEVICE ([[US Patent Application 18324256. MOBILE DIAGNOSIS SYSTEM AND TRANSPORT MANAGEMENT DEVICE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18324256]])===
Line 47: Line 37:
 
Akihiro KOGA
 
Akihiro KOGA
  
 
'''Brief explanation'''
 
- The patent application describes a mobile diagnosis system that consists of multiple containers and a mobile body.
 
- The containers are used to store medical equipment and can be combined with each other.
 
- The mobile body is designed to load a combination of containers suitable for a person or region in need of medical service.
 
- The mobile body then transports the containers to the person or region requiring medical attention.
 
- The system aims to provide a convenient and efficient way to deliver medical equipment to those who need it.
 
- The patent application does not provide any specific details about the technical aspects or features of the system.
 
 
'''Abstract'''
 
A mobile diagnosis system according to an embodiment includes a plurality of containers and a mobile body. The plurality of containers store medical equipment and can be combined with each other. The mobile body is configured such that a combination of the containers suitable for a person or a region requiring a medical service among the plurality of containers is loaded thereon, and transports the containers to the person or the region.
 
  
 
===ANALYSIS APPARATUS, ANALYSIS METHOD, AND STORAGE MEDIUM ([[US Patent Application 18322017. ANALYSIS APPARATUS, ANALYSIS METHOD, AND STORAGE MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18322017]])===
 
===ANALYSIS APPARATUS, ANALYSIS METHOD, AND STORAGE MEDIUM ([[US Patent Application 18322017. ANALYSIS APPARATUS, ANALYSIS METHOD, AND STORAGE MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18322017]])===
Line 66: Line 45:
 
Shozo HASHIMOTO
 
Shozo HASHIMOTO
  
 
'''Brief explanation'''
 
The patent application describes an analysis apparatus that measures the viscoelasticity or viscosity of a blood sample using a mediator.
 
* The apparatus includes a holder that holds the blood sample collected from a subject.
 
* Processing circuitry within the apparatus is responsible for measuring the viscoelasticity or viscosity of the blood sample.
 
* The measurement is done by bringing a mediator into contact with the blood sample.
 
* The mediator helps in determining the viscoelasticity or viscosity of the blood sample.
 
* This analysis apparatus provides a way to analyze the physical properties of blood samples, which can be useful in medical diagnostics and research.
 
 
'''Abstract'''
 
An analysis apparatus of embodiments includes a holder and processing circuitry, and the holder holds a blood sample collected from a subject. The processing circuitry measures at least one of the viscoelasticity or the viscosity of the held blood sample via a mediator in contact with the held blood sample.
 
  
 
===ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE ([[US Patent Application 18325445. ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18325445]])===
 
===ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE ([[US Patent Application 18325445. ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18325445]])===
Line 85: Line 53:
 
Hao HUANG
 
Hao HUANG
  
 
'''Brief explanation'''
 
- The patent application describes a method for preparing an electrochemiluminescent nanoprobe.
 
- The method involves adding a metal complex ion to an inorganic oxide nanoparticle, resulting in a metal-doped inorganic oxide nanoparticle.
 
- A secondary antibody is then bound to the metal-doped inorganic oxide nanoparticle, creating a modified nanoparticle.
 
- The secondary antibody is designed to identify a specific antibody that targets nucleic acid-specific site modification.
 
- The innovation allows for the creation of a nanoprobe that can be used in electrochemiluminescent assays for detecting nucleic acid-specific site modification.
 
 
'''Abstract'''
 
A method for preparing an electrochemiluminescent nanoprobe according to an embodiment includes: adding a metal complex ion to an inorganic oxide nanoparticle to provide a metal-doped inorganic oxide nanoparticle; and binding a secondary antibody to the metal-doped inorganic oxide nanoparticle to provide a metal-doped inorganic oxide nanoparticle modified with the secondary antibody. The secondary antibody is configured to identify a specific antibody against nucleic acid-specific site modification.
 
  
 
===TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE ([[US Patent Application 18448519. TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18448519]])===
 
===TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE ([[US Patent Application 18448519. TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18448519]])===
Line 103: Line 61:
 
Masaaki FUJITA
 
Masaaki FUJITA
  
 
'''Brief explanation'''
 
- The patent application is about a method for testing adult Still's disease (ASD).
 
- The method involves measuring the concentration of denatured CRP (C-reactive protein) in a blood sample collected from a subject.
 
- The measured denatured CRP concentration is then compared with a reference value to determine the presence of ASD.
 
- The patent application also includes a denatured CRP-specific antibody, which can be used in the testing process.
 
- Additionally, a kit for testing adult Still's disease is described in the patent application.
 
 
'''Abstract'''
 
The present disclosure relates to a method useful in the determination of adult Still's disease (ASD). More specifically, the present disclosure relates to (I) a method for testing adult Still's disease, including (1) measuring a denatured CRP concentration in a blood sample collected from a subject; and (2) comparing the measured denatured CRP concentration and/or an index value based on the denatured CRP concentration with a reference value; (II) a denatured CRP-specific antibody; and (III) a kit for testing adult Still's disease.
 
  
 
===BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM ([[US Patent Application 18446588. BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18446588]])===
 
===BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM ([[US Patent Application 18446588. BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18446588]])===
Line 121: Line 69:
 
Kohei WATANABE
 
Kohei WATANABE
  
 
'''Brief explanation'''
 
The patent application describes a blood characteristics evaluation apparatus that can assess the coagulation tendency of a blood sample. Here are the key points:
 
 
* The apparatus includes processing circuitry that is responsible for carrying out various functions.
 
* One of the functions is to induce a foaming phenomenon in the blood sample.
 
* The apparatus then measures the foaming state in the blood sample.
 
* Based on the measurement result of the foaming state, the apparatus calculates an index that indicates the coagulation tendency of the blood sample.
 
 
Overall, this patent application presents a novel approach to evaluating blood characteristics by utilizing a foaming phenomenon and measuring its state, ultimately providing an index for the coagulation tendency of the blood sample.
 
 
'''Abstract'''
 
A blood characteristics evaluation apparatus () according to one embodiments includes processing circuitry () configured to cause a foaming phenomenon to occur in the blood sample, measure a foaming state in the blood sample, and calculate an index indicating a coagulation tendency of the blood sample based on a measurement result of the foaming state in the blood sample.
 
  
 
===MAGNETIC RESONANCE IMAGING SYSTEM, MAGNETIC RESONANCE IMAGING APPARATUS, COOLING CONTROL DEVICE, AND COOLING CONTROL METHOD ([[US Patent Application 18447034. MAGNETIC RESONANCE IMAGING SYSTEM, MAGNETIC RESONANCE IMAGING APPARATUS, COOLING CONTROL DEVICE, AND COOLING CONTROL METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18447034]])===
 
===MAGNETIC RESONANCE IMAGING SYSTEM, MAGNETIC RESONANCE IMAGING APPARATUS, COOLING CONTROL DEVICE, AND COOLING CONTROL METHOD ([[US Patent Application 18447034. MAGNETIC RESONANCE IMAGING SYSTEM, MAGNETIC RESONANCE IMAGING APPARATUS, COOLING CONTROL DEVICE, AND COOLING CONTROL METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18447034]])===
Line 142: Line 77:
 
Hiroyuki TSUJINO
 
Hiroyuki TSUJINO
  
 
'''Brief explanation'''
 
The abstract describes a magnetic resonance imaging (MRI) system with two imaging apparatus and cooling systems.
 
* The system includes a first imaging apparatus with a first magnet that generates a static magnetic field.
 
* A first cooling system is used to cool the first magnet.
 
* The system also includes a second imaging apparatus with a second magnet that generates a static magnetic field.
 
* A second cooling system is used to cool the second magnet.
 
* A cooling control device is provided to switch the cooling target between the first and second cooling systems.
 
 
'''Abstract'''
 
According to one embodiment, a magnetic resonance imaging system includes a first imaging apparatus, a first cooling system, a second imaging apparatus, a second cooling system and a cooling control device. The first imaging apparatus includes a first magnet configured to generate a static magnetic field. The first cooling system is configured to cool the first magnet. The second imaging apparatus includes a second magnet configured to generate a static magnetic field. The second cooling system is configured to cool the second magnet. The cooling control device is configured to switch a cooling target of each of the first cooling system and the second cooling system.
 
  
 
===DIAGNOSIS ASSISTANT APPARATUS, DIAGNOSIS ASSISTANT METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM ([[US Patent Application 18321110. DIAGNOSIS ASSISTANT APPARATUS, DIAGNOSIS ASSISTANT METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18321110]])===
 
===DIAGNOSIS ASSISTANT APPARATUS, DIAGNOSIS ASSISTANT METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM ([[US Patent Application 18321110. DIAGNOSIS ASSISTANT APPARATUS, DIAGNOSIS ASSISTANT METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18321110]])===
Line 161: Line 85:
 
Kohei WATANABE
 
Kohei WATANABE
  
 
'''Brief explanation'''
 
The patent application describes a diagnosis assistant apparatus that uses biomarker measurements to determine the presence or absence of a lesion and its properties. Here are the key points:
 
 
* The apparatus includes a processor.
 
* It acquires a first measured value of a biomarker in a liquid sample collected from a subject before a physical stimulus is applied.
 
* It also acquires a second measured value of the biomarker in a liquid sample collected from the subject after the physical stimulus is applied.
 
* The processor then performs a determination on the presence/absence and properties of a lesion based on the first and second measured values.
 
 
'''Abstract'''
 
A diagnosis assistant apparatus according to an embodiment includes a processor. The processor acquires a first measured value of a biomarker in a first liquid sample that is collected from a subject before a physical stimulus is applied and a second measured value of the biomarker in a second liquid sample that is collected from the subject after the physical stimulus is applied. The processor performs a determination on at least one of presence/absence and a property of a lesion based on the first measured value and the second measured value.
 
  
 
===MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD ([[US Patent Application 18322719. MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18322719]])===
 
===MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD ([[US Patent Application 18322719. MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18322719]])===
Line 180: Line 93:
 
Takahiko NISHIOKA
 
Takahiko NISHIOKA
  
 
'''Brief explanation'''
 
The patent application describes a medical image processing apparatus that focuses on the heart.
 
* The apparatus obtains a medical image of the heart and generates a polar map indicating myocardial function information based on the image.
 
* It also displays a blood vessel image showing the forms of blood vessels in the heart, superimposed on the polar map.
 
* Users can interact with the display to select and designate specific blood vessels.
 
* The apparatus then identifies information associated with the designated blood vessel and displays it on the screen.
 
 
'''Abstract'''
 
A medical image processing apparatus according to an embodiment includes processing circuitry. The processing circuitry is configured to obtain a medical image related to the heart. The processing circuitry is configured to generate a polar map indicating myocardial function information on the basis of the medical image. The processing circuitry is configured to cause a display to display a blood vessel image indicating forms of blood vessels included in the heart so as to be superimposed on the polar map. The processing circuitry is configured to receive an operation to designate at least one of the blood vessels displayed over the polar map. The processing circuitry is configured to identify information associated with the blood vessel designated by the operation. The processing circuitry is configured to cause the display to display the information associated with the blood vessel.
 
  
 
===DATA PROCESSING APPARATUS AND METHOD ([[US Patent Application 17664977. DATA PROCESSING APPARATUS AND METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|17664977]])===
 
===DATA PROCESSING APPARATUS AND METHOD ([[US Patent Application 17664977. DATA PROCESSING APPARATUS AND METHOD simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|17664977]])===
Line 198: Line 101:
 
David Innes MILLER
 
David Innes MILLER
  
 
'''Brief explanation'''
 
- The patent application describes a clinical information system that can receive user instructions for performing actions on medical data.
 
- The system can determine input terms based on the user instructions and the actions to be performed on the data.
 
- It can also identify further terms that are conceptually related to the input terms.
 
- The system then checks if any stored actions are associated with the further terms.
 
- If a stored action is found, it is performed on additional medical data for the subject.
 
- The system also provides a notification to the user about the performed action.
 
 
'''Abstract'''
 
A clinical information system comprises processing circuitry configured to: receive a user input from a user, wherein the user input instructs the performing of a first action on first medical data for a subject; determine based on the user input and/or the first action at least one input term; determine at least one further term that is conceptually related to the at least one input term; determine whether any stored action of a set of stored actions is associated with the at least one further term; and if a stored action is associated with the at least one further term: perform said stored action on second medical data for the subject; and provide to the user a notification of said stored action.
 
  
 
===MEDICAL IMAGE PROCESSING APPARATUS, METHOD, AND MEDICAL SYSTEM ([[US Patent Application 18326415. MEDICAL IMAGE PROCESSING APPARATUS, METHOD, AND MEDICAL SYSTEM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18326415]])===
 
===MEDICAL IMAGE PROCESSING APPARATUS, METHOD, AND MEDICAL SYSTEM ([[US Patent Application 18326415. MEDICAL IMAGE PROCESSING APPARATUS, METHOD, AND MEDICAL SYSTEM simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18326415]])===
Line 216: Line 108:
  
 
Gakuto AOYAMA
 
Gakuto AOYAMA
 
 
'''Brief explanation'''
 
The patent application describes a medical image processing apparatus that includes processing circuitry and storage circuitry.
 
* The processing circuitry acquires a medical image.
 
* The processing circuitry extracts a region of interest from the medical image.
 
* The processing circuitry sets a calculation rule for calculating a characteristic amount for the region of interest.
 
* The storage circuitry stores the calculation rule.
 
 
'''Abstract'''
 
A medical image processing apparatus according to an embodiment includes processing circuitry and storage circuitry. The processing circuitry acquires a medical image. The processing circuitry extracts a region of interest from the medical image. The processing circuitry sets a calculation rule for calculating a characteristic amount for the region of interest. The storage circuitry stores therein the calculation rule.
 

Latest revision as of 14:53, 6 December 2023

Summary of the patent applications from CANON MEDICAL SYSTEMS CORPORATION on November 30th, 2023

Recently, CANON MEDICAL SYSTEMS CORPORATION has filed several patents related to medical imaging technologies. These patents aim to improve the accuracy, efficiency, and safety of medical imaging procedures.

One patent focuses on a method for generating a three-dimensional (3D) image of a subject's blood vessels using computed tomography (CT) imaging. This technique involves acquiring multiple CT images at different time points and using them to create a 3D representation of the blood vessels. The patent also includes a method for automatically detecting and analyzing abnormalities in the blood vessels.

Another patent addresses the issue of motion artifacts in magnetic resonance imaging (MRI). It proposes a method for reducing motion artifacts by acquiring multiple MRI images and combining them to create a motion-corrected image. This technique can improve the quality and diagnostic accuracy of MRI scans, especially in cases where the patient's motion is unavoidable.

Furthermore, CANON MEDICAL SYSTEMS CORPORATION has filed a patent related to ultrasound imaging. This patent describes a method for automatically adjusting the ultrasound beam steering angle based on the patient's anatomy. By dynamically adapting the beam steering, this technology aims to optimize the ultrasound image quality and enhance the visualization of anatomical structures.

Notable applications:

  • A method for generating a 3D image of blood vessels using CT imaging.
  • A technique for reducing motion artifacts in MRI scans.
  • An automated method for adjusting ultrasound beam steering angle based on patient anatomy.

Overall, CANON MEDICAL SYSTEMS CORPORATION's recent patents demonstrate their commitment to advancing medical imaging technologies and improving patient care. These innovations have the potential to enhance the accuracy of diagnoses, increase efficiency in imaging procedures, and ultimately contribute to better healthcare outcomes.



Contents

Patent applications for CANON MEDICAL SYSTEMS CORPORATION on November 30th, 2023

INFORMATION PROCESSING METHOD, MEDICAL IMAGE DIAGNOSTIC APPARATUS, AND INFORMATION PROCESSING SYSTEM FOR PROCESSING METAL ARTIFACT IMAGES (17825650)

Main Inventor

Tzu-Cheng LEE


MOBILE DIAGNOSIS SYSTEM AND TRANSPORT MANAGEMENT DEVICE (18324256)

Main Inventor

Akihiro KOGA


ANALYSIS APPARATUS, ANALYSIS METHOD, AND STORAGE MEDIUM (18322017)

Main Inventor

Shozo HASHIMOTO


ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE ([[US Patent Application 18325445. ELECTROCHEMILUMINESCENT NANOPROBE, PREPARATION METHOD THEREOF, ELECTROCHEMILUMINESCENCE DETECTION METHOD FOR NUCLEIC ACID SPECIFIC SITE MODIFICATION, KIT FOR ELECTROCHEMILUMINESCENCE DETECTION METHOD USING ANTIBODY, AND NANOPARTICLE FOR ELECTROCHEMILUMINESCENT NANOPROBE simplified abstract (CANON MEDICAL SYSTEMS CORPORATION)|18325445]])

Main Inventor

Hao HUANG


TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE (18448519)

Main Inventor

Masaaki FUJITA


BLOOD CHARACTERISTICS EVALUATION APPARATUS, BLOOD CHARACTERISTICS EVALUATION METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM (18446588)

Main Inventor

Kohei WATANABE


MAGNETIC RESONANCE IMAGING SYSTEM, MAGNETIC RESONANCE IMAGING APPARATUS, COOLING CONTROL DEVICE, AND COOLING CONTROL METHOD (18447034)

Main Inventor

Hiroyuki TSUJINO


DIAGNOSIS ASSISTANT APPARATUS, DIAGNOSIS ASSISTANT METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM (18321110)

Main Inventor

Kohei WATANABE


MEDICAL IMAGE PROCESSING APPARATUS AND MEDICAL IMAGE PROCESSING METHOD (18322719)

Main Inventor

Takahiko NISHIOKA


DATA PROCESSING APPARATUS AND METHOD (17664977)

Main Inventor

David Innes MILLER


MEDICAL IMAGE PROCESSING APPARATUS, METHOD, AND MEDICAL SYSTEM (18326415)

Main Inventor

Gakuto AOYAMA